ResearchNew Earnings Calendar Economic Calendar

AI Financial Intelligence
Professional analysis of central bank decisions

Markets

News
Forex
Stocks
Crypto
Gold
Commodities
Indices
ETFs

Analysis

Fed
ECB
COT
Economic Calendar

Learn

Service Guide
Oil

Company

About
Contact
Data Methodology
AI Disclosure
Pricing
Enterprise
Terms
Privacy
Security
WhatsApp

Status data is currently unavailable

The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookiesPrivacy Policy

AI Financial Intelligence
Professional analysis of central bank decisions

Markets

News
Forex
Stocks
Crypto
Gold
Commodities
Indices
ETFs

Analysis

Fed
ECB
COT
Economic Calendar

Learn

Service Guide
Oil

Company

About
Contact
Data Methodology
AI Disclosure
Pricing
Enterprise
Terms
Privacy
Security
WhatsApp

Status data is currently unavailable

The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

BreakingStocks

Abbott Reports 14.5% Sales Growth in Q3 2026 and Reaffirms Guidance

First Detected: Oct 21, 2026, 11:37 AM

Last Update: about 1 hour ago

1 update

Event Summary

Abbott reported a 14.5% increase in sales for the third quarter of 2026. Adjusted diluted earnings per share (EPS) reached $1.42, and the company reaffirmed its financial guidance for the full year. These results, announced on October 21, highlight the company's steady performance and operational consistency.

Timeline

Latest developmentabout 7 hours ago

Abbott to Spin Off Nutrition Business and Lowers 2026 Sales Forecast

The company plans to separate its $8.5 billion nutrition unit into an independent entity while lowering annual growth targets due to medical device market weakness.

Read the full story

Key facts

Abbott reported third-quarter sales growth of 14.5 percent.
Adjusted diluted EPS reached $1.42 for the third quarter with reaffirmed full-year guidance.